BRIEF-Paion reports positive remimazolam headline data in phase III study in procedural sedation for colonoscopy

* Said on Sunday remimazolam met its primary efficacy

endpoint in the first study of its pivotal U.S. Phase III

program in patients undergoing procedural sedation

Read more